Remicade® infliximab

Find a Specialist | Contact Us | For Healthcare Professionals

Psoriasis
Rheumatoid Arthritis
Psoriatic Arthritis
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Ankylosing Spondylitis
Important Safety Information


 

REMICADE and Plaque Psoriasis

Fast, long-lasting improvement proven in clinical studies.

Outstanding response:

  • In a clinical study, 8 out of 10 patients achieved at least 75% skin clearance within 10 weeks.

Fast results:

  • In another clinical study, some patients saw improvement in as little as two weeks.

Long-lasting improvement:

  • In both studies, most of these patients maintained skin clearance up to one year of treatment.

REMICADE is approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE is appropriate considering other available therapies.

REMICADE is not for everyone. Please read the Medication Guide for REMICADE and discuss with your doctor.

Experience

  • REMICADE has been used to treat more than one million patients worldwide with conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, Crohn's disease in adults, pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis.

Treatments as few as six times per year

  • REMICADE is given as a two-hour IV infusion by a healthcare professional. After the first three doses, you will need REMICADE only once every eight weeks. That could be as few as six times a year.

Insurance coverage

  • REMICADE is covered by most major insurance plans, including Medicare and Medicaid. Coverage policies may vary by insurer or even between plans offered by the same insurer. If you have any questions about insurance coverage or reimbursement, you should first call your insurance company or Medicare. If you have questions or concerns, or if you need additional information related to medical coverage for REMICADE, you may call AccessOneSM at 1-888-ACCESS-1 (222-3771) for free assistance.

Is REMICADE right for you?

Individual results may vary. Talk to your doctor to see if REMICADE is right for you. Please read the Medication Guide for REMICADE and discuss any questions or symptoms with your doctor.

REMICADE is approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE is appropriate considering other available therapies.

Sign up now to receive your free information packet and helpful updates that include:

  • Medication Guide for REMICADE
  • The "Real Transformation" DVD. True stories from psoriasis patients and their success with REMICADE
  • Treatment information
  • Doctor Discussion Guide
  • More personal stories from people like you

Sign me up

NEXT: Understanding Psoriasis

Resource Center
REMICADE News
and Updates


IMPORTANT SAFETY INFORMATION | Privacy Policy | Legal Notice | Site Map | About Centocor Ortho Biotech Inc.

© Centocor Ortho Biotech Inc. 1999-2009
This site is published by Centocor Ortho Biotech Inc. which is solely responsible for its contents.
It is intended for residents from the United States.
Last Updated: January 19, 2009